Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 272 results found since Jan 2013.

Postherpetic Neuralgia and Trigeminal Neuralgia.
Authors: Feller L, Khammissa RAG, Fourie J, Bouckaert M, Lemmer J Abstract Postherpetic neuralgia (PHN) is an unpredictable complication of varicella zoster virus- (VZV-) induced herpes zoster (HZ) which often occurs in elderly and immunocompromised persons and which can induce psychosocial dysfunction and can negatively impact on quality of life. Preventive options for PHN include vaccination of high-risk persons against HZ, early use of antiviral agents, and robust management of pain during the early stage of acute herpes zoster. If it does occur, PHN may persist for months or even years after resolution of the H...
Source: Pain Research and Treatment - January 24, 2018 Category: Anesthesiology Tags: Pain Res Treat Source Type: research

Recombinant zoster vaccine (Shingrix ®): a new option for the prevention of herpes zoster and postherpetic neuralgia.
This article reviews the brief history, efficacy, and safety of the two vaccines and discusses the advantage of RZV over LZV based on the available literature. PMID: 32606264 [PubMed]
Source: Korean Journal of Pain - July 3, 2020 Category: Anesthesiology Tags: Korean J Pain Source Type: research

Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment.
Authors: Jeon YH Abstract Herpes zoster (HZ) is a transient disease caused by the reactivation of latent varicella zoster virus (VZV) in spinal or cranial sensory ganglia. It is characterized by a painful rash in the affected dermatome. Postherpetic neuralgia (PHN) is the most troublesome side effect associated with HZ. However, PHN is often resistant to current analgesic treatments such as antidepressants, anticonvulsants, opioids, and topical agents including lidocaine patches and capsaicin cream and can persist for several years. The risk factors for reactivation of HZ include advanced age and compromised cell-m...
Source: Korean Journal of Pain - December 1, 2015 Category: Anesthesiology Tags: Korean J Pain Source Type: research

Modalities in managing postherpetic neuralgia.
Authors: Shrestha M, Chen A Abstract Postherpetic neuralgia (PHN) is the most troublesome side effect of Herpes Zoster (HZ), which mainly affects the elderly and immunocompromised populations. Despite the current advancement of treatments, PHN persists in many individuals influencing their daily activities and reducing their quality of life. Anticonvulsants, antidepressants, topical therapies including lidocaine and capsaicin, and opioids, are the most widely used therapies for the treatment of PHN. These medications come with their adverse effects, so they should be used carefully with the elderly or with patients...
Source: Korean Journal of Pain - October 13, 2018 Category: Anesthesiology Tags: Korean J Pain Source Type: research

I Got Shingles As A Healthy 34-Year-Old, And It Was The Worst Pain I've Ever Felt
By Amanda MacMillan A few weeks after my 34th birthday, my husband and I went for a Saturday hike — a weekly ritual we’d started after moving to New York State’s Catskill Mountains region a few months earlier. I’d been feeling a bit under the weather, and I hoped the fresh autumn air would do me good. It didn’t. Later that night, I had chills and my skin felt strangely sensitive, like when you’re coming down with the flu. On top of that, it felt like I had pulled a muscle in my back or chest; when I breathed or stretched certain ways, I’d get shooting pains across my body. I blamed...
Source: Healthy Living - The Huffington Post - May 4, 2017 Category: Consumer Health News Source Type: news

Neuropathic pain--a management update.
This article summaries the diagnosis and management of four common neuropathic pain presentations. DISCUSSION: A validated diagnostic screening tool can help identify patients with neuropathic pain. A systematic approach to clinical assessment and investigation will clarify the diagnosis. Good glycaemic control is important in the prevention and management of diabetic polyneuropathy; management options include antidepressants, gabapentinoids and controlled release opioids. Pain that lasts for more than 3 months after the onset of a herpes zoster infection is called 'postherpetic neuralgia'; management options include ...
Source: Australian Family Physician - March 1, 2013 Category: Primary Care Authors: Votrubec M, Thong I Tags: Aust Fam Physician Source Type: research

Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009¿2010): a GP-based prospective cohort study
Conclusions: These results suggest that HZ and PHN represent an important burden of disease in the elderly. There is a need for interventions that can prevent and reduce the burden of HZ to help improve the quality of life of the elderly. These data may be useful as baseline epidemiology data for the assessment of the impact of the VZV vaccine in Italy, after its implementation.
Source: BMC Infectious Diseases - December 6, 2014 Category: Infectious Diseases Authors: Hélène BricoutEmilia PerinettiPaolo MarchettiniPietro RagniCarla ZottiGiovanni GabuttiAntonio VolpiElisabetta Franco Source Type: research

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across three randomized, placebo-controlled trials
Pain. 2022 Aug 19. doi: 10.1097/j.pain.0000000000002760. Online ahead of print.ABSTRACTClinicalTrials.gov: NCT01165177; NCT01165229; NCT01610414.PMID:36066965 | DOI:10.1097/j.pain.0000000000002760
Source: Herpes - September 6, 2022 Category: Infectious Diseases Authors: Joon Hyung Kim Robert Johnson Martina Kovac Anthony L Cunningham Mohamed Amakrane Keith M Sullivan Alemnew F Dagnew Desmond Curran Anne Schuind Source Type: research

Herpes zoster after COVID-19 vaccination, aspect of pain medicine: a retrospective, single-center study
CONCLUSIONS: COVID-19 vaccination-related HZ showed clinical features similar to those ofthe other HZ.PMID:36746903 | DOI:10.17085/apm.22207
Source: Herpes - February 6, 2023 Category: Infectious Diseases Authors: Ji Hye Lee Yu Yil Kim Hyun Joo Heo Ji Hun Park Hyung Gu Cho Geonbo Kim Source Type: research

Interpretation of the expert consensus on the whole-process management of herpes zoster-associated pain
This article gives a detailed interpretation of the associated content in the consensus.PMID:36319169 | DOI:10.3760/cma.j.cn112137-20220415-00814
Source: Herpes - November 1, 2022 Category: Infectious Diseases Authors: B T Liu K Xue B F Fan Yong Cui Source Type: research

Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination
Hum Vaccin Immunother. 2022 Apr 1:1-11. doi: 10.1080/21645515.2022.2040328. Online ahead of print.ABSTRACTPLAIN LANGUAGE SUMMARYWhat is the context? Herpes zoster or shingles and its complications such as postherpetic neuralgia - a painful condition that affects the nerve fibers and skin - may lead to complex pain that can be addressed using opioids in some patients.The recombinant zoster vaccine (RZV) vaccine prevents shingles and, therefore, may reduce the use of opioids and the negative health outcomes and costs associated with it.What is new? In this retrospective medical claims study, including patients between 2012 a...
Source: Herpes - April 1, 2022 Category: Infectious Diseases Authors: Jean-Etienne Poirrier Jessica K DeMartino Saurabh Nagar Justin Carrico Katherine Hicks Juliana Meyers Jeffrey Stoddard Source Type: research

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study
Conclusions: Postherpetic neuralgia risk was increased for a number of patient characteristics and comorbidities, notably with age and among those with severe immunosuppression. As zoster vaccination is contraindicated for patients with severe immunosuppression, strategies to prevent zoster in these patients, which could include the new subunit zoster vaccine, are an increasing priority.
Source: Neurology - July 3, 2016 Category: Neurology Authors: Forbes, H. J., Bhaskaran, K., Thomas, S. L., Smeeth, L., Clayton, T., Mansfield, K., Minassian, C., Langan, S. M. Tags: Viral infections, Neuropathic pain, Cohort studies, Risk factors in epidemiology ARTICLE Source Type: research